Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ford-Dunn, S
Right arrow Articles by Quin, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ford-Dunn, S
Right arrow Articles by Quin, J
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Diabetes
*Diabetes Type 1
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Management of diabetes during the last days of life: attitudes of consultant diabetologists and consultant palliative care physicians in the UK

S Ford-Dunn

Brighton and Sussex University Hospitals, suzanne_fd{at}hotmail.com

A Smith

Brighton and Sussex University Hospitals

J Quin

Brighton and Sussex University Hospitals

Diabetes is an increasingly common condition and hence, managing dying patients with diabetes as a co-morbidity will become a frequent challenge. It is uncertain whether there is net beneficence in preventing hyperglycaemia in diabetic patients during the terminal phase or whether the distress involved in administering therapy and blood glucose monitoring may outweigh this ordeal. Since there is no available evidence upon which to base clinical decisions, a semi-structured questionnaire based around three clinical vignettes was sent to consultants in diabetes and palliative care in the UK. There was consensus of opinion from both groups of consultants that treatment and monitoring should be stopped in patients with type 2 diabetes, once in the terminal phase. There was less consensus regarding management of type 1 diabetes. Practical issues were raised by both groups of consultants and clinical guidelines are suggested.

Key Words: diabetes • dying • withdrawing treatment

Palliative Medicine, Vol. 20, No. 3, 197-203 (2006)
DOI: 10.1191/0269216306pm1128oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Palliat MedHome page
D. C Currow and A. P Abernethy
The broader implications of diabetes management at the end of life
Palliative Medicine, September 1, 2006; 20(6): 638 - 639.
[PDF]